Trial Profile
Phase I Study of Axitinib and Temsirolimus in Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Axitinib (Primary) ; Temsirolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 20 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Feb 2012 New trial record